Tag: Home Sleep Testing

NEW YORK – Wesper, the first clinical-grade wireless home sleep lab cleared by the U.S. Food and Drug Administration, has announced a $9.6 million Series A round to accelerate growth and revenue, as well as continue to develop diagnostic sensing technology. Wesper's wireless biometric sensors and algorithms enable at-home medical diagnosis with professional services and ongoing measurement before, during, and after treatment. "Wesper is at the forefront of revolutionizing the sleep industry...

HIGHLANDS RANCH, Colo. – Vivos Therapeutics saw an 18-times increase in the total number of SleepImage Home Sleep Apnea Tests given across its network of trained dentists (known as Vivos Integrated Practices or VIPs) for the three months ended Dec. 31, 2021. The company also reported a 5.7-times increase in the number of VIPs administering HSTs; and a 3-times increase in the average number of HSTs being administered per VIP. “We have always believed that the pathway to getting more patients...

WASHINGTON – AAHomecare, VGM & Associates, the Council for Quality Respiratory Care and 11 other organizations are asking CMS to eliminate the medical record review for home oxygen therapy and to accept the clinician prescription/standard written order as the required documentation for establishing medical necessity.  These changes would protect against fraud and abuse, reduce the burden on clinicians and suppliers, and protect access for Medicare beneficiaries, the groups say in an...

SAN DIEGO – ResMed has bought Ectosense, which makes the NightOwl home sleep test.  The NightOwl, approved by the U.S. Food and Drug Administration, is currently sold in the United States, Australia, New Zealand, India and parts of Europe. ResMed has distributed the NightOwl, under the brand ResMed onesleeptest, in Australia, New Zealand and India since 2020, and has been a minority investor in Ectosense since July 2020.  "Sleep labs and home tests each have critical roles to...

CHELMSFORD, Mass., and CAESAREA, Israel – ZOLL Medical Corp. has signed a definitive agreement to acquire all outstanding ordinary shares of Itamar Medical for about $538 million.  Itamar Medical is focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory disorders, including the WatchPAT Home Sleep Apnea Device.  “It is currently estimated that 60% of cardiovascular patients suffer from some...

PITTSBURGH – A new partnership incorporates sovaSage’s TherapistAssist Sleep Assessment & Mask Fitting tool with Breathe’s Diagnostics Home Sleep Test service. This new capability is available for providers using sovaSage TherapistAssist, increasing their efficiencies and improving the care they provide, the two companies say. “Our partnership with Breathe promises to revolutionize how patients are managed in the future,” said William Kaigler, co-founder and CEO of sovaSage,...

CAESAREA, Israel – Itamar Medical has enhanced its WatchPAT product line to include WatchPAT with SleepPath, a new service that allows subjective data to be collected from patients through the WatchPAT smartphone app, before and after the home sleep test. The company will offer the new service to sleep clinics, giving them access to digital documentation in one report that combines sleep study metrics and patient self-reported data, replacing traditional paper documentation. Itamar Medical...

CAESAREA, Israel – Ninety-three percent of health care professionals currently use home sleep apnea testing in their practices, according to the results of a recent survey designed by Itamar Medical.  Furthermore, HSAT represents more than 50% of the daily test volume in 66% of the practices surveyed.  “While sleep apnea affects an estimated 54 million to 64 million people in the U.S., roughly 80% of sufferers remain undiagnosed and untreated, largely due to the lack of...

ATLANTA – Itamar Medical’s Joao Mendes-Roter believes there’s a “digital revolution” happening in the home right now that will increase the percentage of sleep tests being conducted there in the long term. The percentage of sleep tests conducted in homes vs. in labs has flip flopped from 30%/70% before the pandemic to 70%/30% during the pandemic, says Mendes-Roter, vice president of digital health marketing for Itamar, which makes the WatchPAT ONE home sleep test. “We...

Kno2 announced partnerships with Stratice Healthcare and DMEhub recently, allowing the HME providers who use those two platforms to access, effectively, any electronic health record system.  Here’s what Therasa Bell, co-founder, president and CTO of Kno2, had to say about how to “do interoperability right,” and how the company made a bet several years ago that information exchange needed to happen beyond the walls of hospitals and physician offices. HME News: How does...